Mesorectal thromboembolism with increased 18F-fluorodeoxyglucose uptake during positron emission tomography/computed tomography in a patient with non-small cell lung cancer

被引:0
|
作者
Sato, Yoshihiro [1 ]
Tsujinaka, Shingo [1 ]
Miura, Tomoya [1 ]
Kitamura, Yoh [1 ]
Sawada, Kentaro [1 ]
Mitamura, Atsushi [1 ]
Yamamoto, Kuniharu [1 ]
Nakano, Toru [1 ]
Katayose, Yu [1 ]
Shibata, Chikashi [1 ]
机构
[1] Tohoku Med & Pharmaceut Univ, Div Gastroenterol & Hepatobiliary Pancreat Surg, Dept Surg, 1-15-1 Fukumuro, Sendai, Miyagi 9838536, Japan
来源
JOURNAL OF SURGICAL CASE REPORTS | 2024年 / 2024卷 / 07期
关键词
computed tomography; fluorodeoxyglucose; mesorectal thromboembolism; non-small cell lung cancer; positron emission tomography; SKIP METASTASIS; PET/CT;
D O I
10.1093/jscr/rjae457
中图分类号
R61 [外科手术学];
学科分类号
摘要
This study presents a case of a 72-year-old man diagnosed with non-small cell lung cancer (cT4N0M0) referred to our hospital for possible surgical treatment of a solitary nodule detected in the mesorectum. The patient had received combined chemoradiotherapy and achieved a complete response 13 months before the presentation. On examination, the mesorectal nodule was incidentally detected during surveillance computed tomography, and the maximum standardized uptake value of the nodule was 10.3. Because of the potential malignancy and need for en-bloc resection of the nodule, we performed laparoscopically assisted high anterior resection of the rectum. The postoperative course was uneventful. Notably, while pathological examination revealed that the mesorectal nodule comprised an intravenous organized thromboembolism, malignancy was not observed. These findings suggest that although positron emission tomography/computed tomography with F-18-fluorodeoxyglucose is useful for the diagnosis of malignant diseases, surgical resection might be the most reliable option for complex cases such as ours.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Prognostic significance of metabolic parameters measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer
    Zhu, Dongyuan
    Ma, Tinghang
    Niu, Zuoxing
    Zheng, Jinsong
    Han, Anqin
    Zhao, Shuqiang
    Yu, Jinming
    LUNG CANCER, 2011, 73 (03) : 332 - 337
  • [32] Pertuzumab and Erlotinib in Patients With Relapsed Non-Small Cell Lung Cancer: A Phase II Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging
    Hughes, Brett
    Mileshkin, Linda
    Townley, Peter
    Gitlitz, Barbara
    Eaton, Keith
    Mitchell, Paul
    Hicks, Rodney
    Wood, Katie
    Amler, Lucas
    Fine, Bernard M.
    Loecke, David
    Pirzkall, Andrea
    ONCOLOGIST, 2014, 19 (02): : 175 - 176
  • [33] Prognostic value of metabolic tumor parameters in pretreatment 18F-fluorodeoxyglucose positron emission tomography-computed tomography scan in advanced non-small cell lung cancer
    Mallick, Ayan
    Das, Jayanta
    Shaw, Manoj Kumar
    Biswas, Bivas
    Ray, Soumendranath
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2021, 36 (02): : 107 - 113
  • [34] CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment
    Saloomeh Vahdat
    Eric K Oermann
    Sean P Collins
    Xia Yu
    Malak Abedalthagafi
    Pedro DeBrito
    Simeng Suy
    Shadi Yousefi
    Constanza J Gutierrez
    Thomas Chang
    Filip Banovac
    Eric D Anderson
    Giuseppe Esposito
    Brian T Collins
    Journal of Hematology & Oncology, 3
  • [35] CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment
    Vahdat, Saloomeh
    Oermann, Eric K.
    Collins, Sean P.
    Yu, Xia
    Abedalthagafi, Malak
    DeBrito, Pedro
    Suy, Simeng
    Yousefi, Shadi
    Gutierrez, Constanza J.
    Chang, Thomas
    Banovac, Filip
    Anderson, Eric D.
    Esposito, Giuseppe
    Collins, Brian T.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
  • [36] An overview of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in giant cell arteritis
    Thibault, Thomas
    Alberini, Jean-Louis
    Billet, Anne-Claire
    Greigert, Helene
    Ramon, Andre
    Devilliers, Herve
    Cochet, Alexandre
    Bonnotte, Bernard
    Samson, Maxime
    FRONTIERS IN MEDICINE, 2024, 11
  • [37] Patterns of brown fat uptake of 18F-fluorodeoxyglucose in positron emission tomography/computed tomography scan
    Chakraborty, Dhritiman
    Bhattacharya, Anish
    Mittal, Bhagwant Rai
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2015, 30 (04): : 320 - 322
  • [38] Early [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic non-small cell lung cancer (NSCLC).
    Helissey, Carole
    Metivier, Denis
    Rousseau, Claire
    Gontier, Eric
    Vedrine, Lionel
    Ceccaldi, Bernard
    Ferrand, Francois-Regis
    Bonardel, Gerald
    Le Moulec, Sylvestre
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Impact of whole-body 18F-fluorodeoxyglucose positron emission tomography on therapeutic management of non-small cell lung cancer
    Heo, Eun Young
    Yang, Seock-Chul
    Yoo, Chul-Gyu
    Han, Sung Koo
    Shim, Young-Soo
    Kim, Young Whan
    RESPIROLOGY, 2010, 15 (08) : 1174 - 1178
  • [40] An unexpected abdominal 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) in a patient with limited stage small cell lung cancer
    Decoster, Lynn
    Stroobants, Sigrid
    Verbeken, Eric
    Nackaerts, Kris
    Vansteenkiste, Johan
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) : 174 - 176